↓ Skip to main content

Uro-Vaxom® versus placebo for the prevention of recurrent symptomatic urinary tract infections in participants with chronic neurogenic bladder dysfunction: a randomised controlled feasibility study

Overview of attention for article published in Trials, April 2019
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
88 Mendeley